Expertise in
25
conditions

Fabrizio De Benedetti

Rome, IT 
Expertise in
25
conditions
Rome, IT 

Overview

Fabrizio De Benedetti practices practicing medicine in Rome, Italy.

Mr. De Benedetti is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Juvenile Idiopathic Arthritis (JIA), Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Reticulohistiocytoma, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 234 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Rome, Italy
Other Locations
Brescia, Italy
Turin, Italy
Pavia, Italy
Gesu, Italy
Rimini, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Three-period Multicenter Study, With a Randomized-withdrawal, Double-blind, Placebo-controlled Design to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
A Three-period Multicenter Study, With a Randomized-withdrawal, Double-blind, Placebo-controlled Design to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Biological
Study Drug: MAS825
Study Phase: Phase 2
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Pilot, Open-label, Single Arm, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)
A Pilot, Open-label, Single Arm, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)
Enrollment Status: Completed
Publish Date: May 17, 2022
Intervention Type: Drug
Study Drug: Emapalumab Anti-IFN-Gamma Antibody
Study Phase: Phase 2
View 2 Less Clinical Trials

234 Total Publications

Study of Nuclear Effects on Charm Production in Light-Ion Collisions.
Study of Nuclear Effects on Charm Production in Light-Ion Collisions.
Journal: Physical review letters
Published: May 26, 2026

Frequently Asked Questions about Fabrizio De Benedetti

Is Fabrizio De Benedetti a top-rated expert for Juvenile Idiopathic Arthritis (JIA)?

MediFind is an objective health platform that identifies experts based on real-world data. Fabrizio De Benedetti is classified as an Elite expert for Juvenile Idiopathic Arthritis (JIA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fabrizio De Benedetti participate in research or clinical trials?

Yes. Fabrizio De Benedetti has published 234 articles and abstracts on conditions like Juvenile Idiopathic Arthritis (JIA). You can view a list of Fabrizio De Benedetti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Benedetti's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 12 Advanced Conditions
View All 56 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile